) - Products under Development by Companies 17
[3,4] Prior to the introduction of ART) 30-40% of HIV-infected individuals developed CMV retinitis
.  However, the introduction of ART has resulted in a precipitous decline in CMV retinitis
infections, which is particularly evident in the developed world.
The team examined how changes in a gene - known as RPGR - can damage eye cells to cause a disorder known as X-linked retinitis
pigmentosa - a chronic hereditary eye disease characterized by black pigmentation and gradual degeneration of the retina.
En la fotografia de fondo de ojo derecho se observan infiltrados perivasculares blanquecinos confluentes acompanados de bordes hemorragicos, patron caracteristico en "queso cottage con catsup" que inician en la periferia con disposicion centrifuga, compatibles a lesiones caracteristicas de retinitis
hemorragica por CMV.
The Dok Apo Better Vision eye drop is being marketed as a treatment for cataracts, sore eyes, eye irritations, retinitis
and other eye-related diseases but never underwent testing.
Recurrent CMV infections are primarily associated with pneumonitis, colitis, encephalitis, and retinitis
.  CMV retinitis
is known to occur in immunocompromised adults, affecting up to 30% of HIV-positive adults and 5% of immunocompromised children.
Such cavities are known to occur following the resolution of sub-ILM bleed due to various cause including Valsalva retinopathy, (2) Terson syndrome, and also in some retinitis
Four patients were initiated to ART following diagnosis of ocular lesions, three patients for CMV retinitis
and one for Toxoplasma retinochoroiditis.
The research leading to these results was also funded by the Fondazione Roma under the Grants for Biomedical Research: Retinitis
Pigmentosa (RP)-Call for proposals 2013 "Cortical Plasticity in Retinitis
Pigmentosa: an Integrated Study from Animal Models to Humans".
The strabismus was observed in 42 (27.6%) patients, cataract in 39(25.6%), extreme myopia in 32(21.1%), microphthalmia in 13(8.5%), anophthalmia in eight(5.3%), astigmatism in nine(5.9%) and nystagmus in six(3.9%) patients, while keratoconus, glaucoma and retinitis
pigmentosa were in single(0.7%) patient each.
Under the terms of the transaction, Allergan has paid RetroSense a $60 million upfront payment, and has agreed to potential regulatory and commercialization milestone payments related to its lead development program, RST-001, a novel gene therapy for the potential treatment of Retinitis
Under the terms of the transaction, Allergan has paid RetroSense a USD 60m upfront payment, and has agreed to potential regulatory and commercialisation milestone payments related to its lead development programme, RST-001, a novel gene therapy for the potential treatment of Retinitis